Immunome Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMNM is expected to report earnings to rise 9.56% to -54 cents per share on November 17
Q3'25
Est.
$-0.55
Q2'25
Beat
by $0.12
Q1'25
Beat
by $0.14
Q4'24
Missed
by $0.45
Q3'24
Missed
by $0.24
The last earnings report on August 06 showed earnings per share of -50 cents, beating the estimate of -62 cents. With 152.76K shares outstanding, the current market capitalization sits at 843.47M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMNM showed earnings on August 06, 2025. You can read more about the earnings report here.